Israeli biotech NeuroQuest is to begin clinical trials of its blood test for early diagnosis of Alzheimer’s disease. Human trials in Israel have already proved 87% accurate – with blood tests, anything over 70% is considered medically significant.

http://www.israel21c.org/blood-test-for-alzheimers-begins-clinical-trials/